Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin/Ezetimibe vs Rosuvastatin in T2DM with Hypercholesterolemia
NCT03446261Phase 4Completed
- Sponsor
- Yuhan
- Start
- Feb 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in hypercholesterolemia, sponsored by Yuhan. Started Feb 2018; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT03446261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03446261.